Table 1:
Summary of 1-year and 5-year metabolic outcomes after islet transplantation since 2004
| 1 year | 5 years | |||||
|---|---|---|---|---|---|---|
| Median (IQR) | Minimum-maximum | Number of study arms (patients) | Median (IQR) | Minimum-maximum | Number of study arms (patients) | |
| Transplant function | ||||||
| ITA recipients | 93% (75–100) | 50–100% | 22 (254) | 81 (78–100) | 74–100% | 6 (34) |
| IAK or SIK recipients | 93% (88–100) | 86–100% | 5 (52) | 80 (74–85) | 74–85% | 2 (24) |
| Insulin independence | ||||||
| ITA recipients | 67% (50–82) | 38–100% | 23 (170) | 40 (14–50) | 8–100% | 7 (20) |
| IAK or SIK recipients | 51% (28–74) | 20–83% | 6 (21) | 32 (9–54) | 9–54% | 3 (7) |
| HbA1c <7% (53 mmol/mol) and no SHEs | ||||||
| ITA recipients | 82% (69–94) | 40–100% | 9 (121) | 54 (50–90) | 50–100% | 4 (13) |
| IAK or SIK recipients | 86% (80–86) | 80–86% | 3 (18) | 59 (58–60) | 58–60% | 2 (7) |